← Leaderboards
Daniel Ian Chasman
Brigham And Women'S Hospital
$2,357,993
Attributed
$3,779,985
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2015–21$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,779,985 · 4
By mechanism
R61$2,065,041 · 1
R21$936,000 · 2
R01$778,944 · 1
Top collaborators
- William G Christen1 shared
- Pamela M. Rist1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Pamela M. Rist$3,009,608
- William G Christen$8,237,211
- Tobias Kurth$1,480,068
- Robert Yuk Lung Zee$370,854
- Debra A Schaumberg$6,275,999
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanCohortGenomeReportingAurasFunctional DisorderPathway InteractionsMigraineGeneticFollow-UpBaseAllelesHeadacheGenome Wide Association StudyComorbidityGenome-WideHeadache DisordersGenetic AnalysisBiologicalClassificationCharacteristicsGenesBiologyGenetic Information
Grant awards (6)
Plasma metabolite and proteome signatures for migraine classification$2,065,041
R61 · FY2021 · NS · contact PI
Causality and/or shared physiology linking plasma lipids and blood pressure to migraine$268,500
R21 · FY2019 · NS · contact PI
Causality and/or shared physiology linking plasma lipids and blood pressure to migraine$223,750
R21 · FY2018 · NS · contact PI
Genetic contribution to sub-classified migraine in the adult population$221,875
R21 · FY2017 · NS · contact PI
Genetic contribution to sub-classified migraine in the adult population$221,875
R21 · FY2016 · NS · contact PI
VITAL-AMD: Prevention of AMD in the VITamin D and OmegA-3 Trial$778,944
R01 · FY2015 · EY